TABLE 2.
Reference | Date of isolation | Type of sample | Underlying condition(s) | Infection | Antifungal susceptibility MIC (mg/liter)b |
Outcome | Country | ||
---|---|---|---|---|---|---|---|---|---|
VRC | ITC | POS | |||||||
1 | July 2012 | BAL fluid | HSCT | Probable IA | >16 | 4 | 1 | Death | Belgium |
2 | December 2009 | Sputum | HSCT | Probable IA | >16 | 4 | 0.25 | Persistent infection | The Netherlands |
January 2010 | Ear | Chronic otitis externals/sinusitis | IA | >16 | >16 | 2 | Persistent infection | The Netherlands | |
January 2010 | Abdominal abscess | SOT | Proven IA | >16 | 2 | 0.5 | Death | The Netherlands | |
February 2010 | Sputum | Cystic fibrosis | No IA | >16 | 4 | 0.5 | Survival | The Netherlands | |
February 2010 | Sputum | Lung carcinoma | No IA | >16 | >16 | 2 | Survival | The Netherlands | |
March 2010 | Sputum | HSCT | Probable IA | >16 | 1 | 0.25 | Death | The Netherlands | |
March 2010 | Sputum | Cystic fibrosis, SOT | Proven IA | >16 | >16 | 0.5 | Survival | The Netherlands | |
May 2010 | Biopsy specimen | Chronic otitis, surgery | Proven IA | >16 | 4 | 1 | Survival | The Netherlands | |
May 2010 | Sputum | Lung fibrosis | None | >16 | >16 | 1 | Survival | The Netherlands | |
June 2010 | Sputum | Traumatism | None | >16 | 1 | 0.25 | Death | The Netherlands | |
July 2010 | Brain biopsy specimen | Beta thalassemia, diabetes mellitus | Proven IA | >16 | 4 | 1 | Death | The Netherlands | |
September 2010 | Sputum | Cystic fibrosis | ABPA | >16 | 2 | 0.5 | Survival | The Netherlands | |
Oct 2010 | Sputum | COPD, SOT | None | >16 | >16 | 2 | Survival | The Netherlands | |
November 2010 | Sputum | COPD | No IA | >16 | >16 | 2 | Survival | The Netherlands | |
January 2011 | Sputum | HSCT | Probable IA | >16 | >16 | 1 | Death | The Netherlands | |
December 2009 to January 2011 | Air sampling | ND | ND | ND | The Netherlands | ||||
8 | 2012–2013 | Soil sampling | >16 | 1 to 2 | 0.25 to 0.5 | India | |||
3 | September 2012 | Sputum | Cystic fibrosis | Colonization | >8* | >8* | 2* | Survival | Germany |
4 | January 2014 | Sputum | Bruton's agammaglobulinemia, SOT | Probable IA | >4* | 0.25 to 0.5* | 0.125 to 0.25* | Death | Denmark |
9 | Not reported | Soil sampling | 16 to >16 | 1 to 2 | 0.25 to 0.5 | Tanzania | |||
5 | November 2013 | BAL fluid | HSCT | Probable IA | >8 | >16 | 1 | Death | Belgium |
7 | September 2012 | BAL fluid | HSCT | Probable IA | 16* | >16* | 0.5* | Death | Germany |
July 2012 | BAL fluid | HSCT | Proven IA | 1* | >16* | 0.5* | Death | Germany | |
Present report | February 2013 | Sputum | Cystic fibrosis | Colonization | >8* | >8* | ND | Survival | France |
March 2014 | Sputum | Cystic fibrosis | Colonization | >8* | 8* | ND | Survival | France |
POS, posaconazole; BAL, bronchoalveolar lavage; HSCT, hematopoietic stem cell transplantation; IA, invasive aspergillosis; SOT, solid-organ transplantation; ABPA, allergic bronchopulmonary aspergillosis; COPD, chronic obstructive pulmonary disease; ND, not determined.
Data represent results determined using CLSI breakpoints, except those indicated with an asterisk, which represent results determined using EUCAST breakpoints.